Human A375 melanoma cell line treated with trifluorothymidine (TFT) and lactimidomycin (LTM)

Human A375 melanoma cell line treated with ciclopirox and crizotinib

Human WM35 melanoma cell line treated with trifluorothymidine(TFT) and lactimidomycin(LTM)

Human WM35 melanoma cell line treated with ciclopirox and crizotinib

Generating IGF1 signatures in human melanoma cell lines by activation of IGF1 or ihibition of IGF1R

Correlating Gene Signatures with Outcome to find Features and Drugs Relevant to Cancer

Reversible reprogramming of memory Tfh cell function during chronic HIV infection

Complement pathway gene activation and rising circulating immune complexes characterize early disease in HIV-associated tuberculosis

Gene expression profiles of rescue with wild type or SUMO double mutant TRIM24

Thorax irradiation of Non-Human Primates induces persistent gene expression changes in blood cells.

Genetic and epigenetic profiles of elderly AML

The IKK complex requires Morgana to drive NF-kB dependent breast cancer metastatisation

Expression level comparison under dividing and quiescent states in human primary fibroblasts

Omeprazole regulate gastric cancer microenvironment by regulate exosomes associated miRNA

RNA-seq analysis of EZH1 knockdown in 5F cells, or EZH1 heterozygous and homozygous knockout YS and AGM cells

EZH1 as a key epigenetic barrier to definitive haematopoiesis during embryonic development

BCL6 expression in AITL could be transcriptionally regulated

Array-CGH data of aneuploid tumor populations of different urothelial cancer sites in one patient

Targeting ribonucleotide reductase by 3-AP in primary effusion lymphoma

MO-OH-Nap and SAHA induce distinct patterns of gene expression in the multiple myeloma cell line U266.